BioXcel Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BTAI for the last quarter is 1.10 M USD, and it's 89.69% higher compared to the previous quarter. The net income of Q2 24 is -8.30 M USD.